Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
Gut microbiome and tumour cachexia: New European research network
Tumour cachexia is a serious syndrome affecting many cancer patients, who not only lose significant…
Study highlights pervasiveness of inflammation in American diet
Almost six in 10 Americans have pro-inflammatory diets, increasing the risk of health problems including…
Spiritual themes, distrust may factor into Black patients’ reluctance to participate in cancer clinical trials
Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients’ decisions…
25-year-long study of Black women links frequent use of lye-based hair relaxers to a higher risk of breast cancer
Kimberly Bertrand, Boston University The big idea Frequent and long-term use of lye-based hair straightening products, or relaxers, may increase…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.